ArticlemedRxiv : the preprint server for health sciences2026
Distinct Connectivity Signatures of Hallucinatory Experiences and Neuromelanin Signal in Adolescents.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Late adolescence is a critical developmental period that typically precedes psychosis onset, yet the neural correlates of subclinical hallucinatory experiences that may impact psychosis risk are poorly understood. Given evidence from adult psychosis models implicating abnormal "triple network" connectivity among the frontoparietal (FPN), default mode (DMN) and salience/cingulo-opercular (CON) networks, as well as dopaminergic abnormalities, we examined whether hallucinatory experiences in adolescents are associated with altered triple network organization and dopamine-related measures in the midbrain. Methods: We performed a cross-sectional analysis of 171 community adolescents aged 14-17 who underwent resting-state functional magnetic resonance imaging and neuromelanin-sensitive MRI. Hallucinatory experience severity was measured using the Specific Psychotic Experiences Questionnaire. Resting-state functional connectivity was calculated among Results: Greater hallucinatory experience severity was associated with stronger connectivity in a subnetwork composed of CON-DMN and CON-FPN edges. Greater hallucinatory experience severity was also associated with lower global network segregation. VTA neuromelanin signal was not directly associated with hallucinatory experience severity, but greater VTA signal predicted lower connectivity in the hallucination-related subnetwork. Greater VTA neuromelanin signal was also associated with a distinct pattern of stronger connectivity within DMN midline regions. Conclusions: These findings implicate altered triple network organization in hallucinatory experiences during late adolescence and suggest that dopamine-related midbrain signal may reflect broader developmental variation in cortical network organization rather than symptom severity directly. Plain Language Summary: Hallucinatory experiences during adolescence may signal increased risk for later psychotic disorders, but their brain basis is unclear. We studied 171 adolescents aged 14-17 using resting-state fMRI to measure brain network activity and neuromelanin-sensitive MRI to estimate dopamine-related midbrain signal. More severe hallucinatory experiences were linked to abnormal communication among three brain networks often implicated in psychosis. Dopamine-related signal was not directly related to hallucination severity but was associated with developmentally relevant network organization. Overall, this work serves to improve our understanding of the risk factors that may contribute to psychosis conversion in adulthood.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.